Perennial Allergic Rhinitis Drug Market
Global Perennial Allergic Rhinitis Drug Market Size, Share, and Trends Analysis Report By Type (Antihistamines, Asapiprant, APC-3000, Bilastine, and Others) and By Application (Hospitals, Clinics, and Others) Forecast 2022-2028
The global perennial allergic rhinitis drug market is anticipated to grow at a significant CAGR of 4.0% during the forecast period 2022-2028. The increased prevalence of perennial allergic rhinitis is a primary factor driving the market's expansion. Furthermore, the market is expanding as a result of new product introductions. For instance, in January 2021, JB Chemicals and Pharmaceuticals Ltd., announced that the US FDA had approved an abbreviated new drug application (ANDA) for Loratadine tablets USP 10 mg. The medication is used to treat pollen-induced allergic rhinitis and upper respiratory tract allergies.
Impact of COVID-19 Pandemic on Global Perennial Allergic Rhinitis Drug Market
The COVID-19 Pandemic had a significant impact on the global perennial allergic rhinitis drug market. In order to treat allergic rhinitis in a COVID-19 patient, perennial allergic rhinitis drug has been used heavily, which has supports the market to grow. Additionally, since the symptoms of COVID-19 and perennial allergic rhinitis are quite similar, the perennial allergic rhinitis drug market saw growth due to the impact of COVID-19 Pandemic, as people went for allergic rhinitis drugs for the treatment of nasal congestion, breathing problem, and many more.
Segmental Outlook
The global perennial allergic rhinitis drug market is segmented based on type and application. Based on the type, the market is sub-segmented into antihistamines, asapiprant, APC-3000, bilastine and others. Based on the application, the market is further sub-segmented into hospitals, clinics, and others.
Global Perennial Allergic Rhinitis Drug Market Share by Type, 2021 (%)
The Antihistamines Segment is Anticipated to Hold a Prominent Share in the Global Perennial Allergic Rhinitis Drug Market
The antihistamines segment is anticipated to hold the significant share in the market due to the demand for antihistamine drugs for the treatment of perennial allergic rhinitis. The antihistamine drug are offered in form of injection, intranasal sprays, and drops according to the need of the patient. The availability of various antihistamines as topical formulations and aerosols, which have the capacity to reduce the infection of allergic rhinitis and heal patients, has also contributed to the market's considerable growth.
Regional Outlooks
The global perennial allergic rhinitis drug market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, and Others), and the Rest of the World (the Middle East & Africa, and Latin America). The Asia Pacific region is expected to develop at the significant rate throughout the forecast period, owing to the rising frequency of allergic illnesses and the pharmaceutical industry's stable rise in recent years. Due to its large population and extensive government activities in the healthcare industry, especially in China is playing a critical role in the Asia-Pacific region. Additionally, the undergoing trials in the region will support to boost the market growth.
Global Perennial Allergic Rhinitis Drug Market Growth, by Region 2022-2028
The North America Region is Estimated to Hold the Major Share in the Global Perennial Allergic Rhinitis Drug Market
The North American region is expected to hold a significant share in the global perennial allergic rhinitis drug market due to the rising incidence of associated with allergy illnesses. According, NCBI, Allergic rhinitis is a chronic upper airway inflammatory disease that affected approximately 60 million adults and children in the US. Additionally, Research activities in the US for novel drug discovery, together with higher regulatory approvals, are expected to boost the expansion of the global perennial allergic rhinitis drug market.
Market Players Outlook
GlaxoSmithKline PLC, Sanofi SA, Merck & Co. inc., Pfizer Inc., Novartis International AG, among others, are some of the leading participants in the global perennial allergic rhinitis drug market. To increase market share around the world, these companies are using a variety of techniques, including mergers and acquisitions, product launches, geographic expansion and collaboration, and partnership. For instance, in January 2022, Glenmark Pharmaceuticals Ltd. announced that its fully-owned Swiss subsidiary Glenmark Specialty S.A. received approval for Ryaltris, a nasal spray fixed-dose prescription drug from the US Food and Drug Administration (FDA). It is used for the treatment of seasonal allergic rhinitis.
The Report Covers
- Market value data analysis of 2021 and forecast to 2028.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global perennial allergic rhinitis drug market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market
1. Report Summary
- Current Industry Analysis and Growth Potential Outlook
- Impact of COVID-19 on The Global Perennial Allergic Rhinitis Drug Market
- Recovery Scenario of Global Perennial Allergic Rhinitis Drug Market
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. BY Region
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. Key Company Analysis
3.1.1. Overview
3.1.2. Financial Analysis
3.1.3. SWOT Analysis
3.1.4. Recent Developments
3.2. Key Strategy Analysis
3.3. Impact of Covid-19 on Key Players
4. Market Segmentation
4.1. Global Perennial Allergic Rhinitis Drug Market by Type
4.1.1. Antihistamines
4.1.2. Asapiprant
4.1.3. APC-3000
4.1.4. Bilastine
4.1.5. Others
4.2. Global Perennial Allergic Rhinitis Drug Market by Application
4.2.1. Hospitals
4.2.2. Clinics
4.2.3. Others
5. Regional Analysis
5.1. North America
5.1.1. United States
5.1.2. Canada
5.2. Europe
5.2.1. UK
5.2.2. Germany
5.2.3. Italy
5.2.4. Spain
5.2.5. France
5.2.6. Rest of Europe
5.3. Asia-Pacific
5.3.1. China
5.3.2. India
5.3.3. Japan
5.3.4. Rest of Asia-Pacific
5.4. Rest of the World
6. Company Profiles
6.1. AstraZeneca PLC
6.2. Boehringer-Ingelhiem International GmbH
6.3. Faes Farma SA
6.4. GlaxoSmithKline PLC
6.5. Glenmark Pharmaceuticals Ltd.
6.6. Hisamitsu Pharmaceuticals Co. Inc.
6.7. Johnson & Johnson Services Ltd.
6.8. Merck & Co. Inc.
6.9. Novartis International AG
6.10. Pfizer Inc.
6.11. Sanofi SA
6.12. Shandong Luoxin Pharmaceutical Group Stock co., ltd.
6.13. Teva Pharmaceutical Industries Ltd.
1. GLOBAL PERENNIAL ALLERGIC RHINITIS DRUG MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
2. GLOBAL ANTIHISTAMINES PERENNIAL ALLERGIC RHINITIS DRUG MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
3. GLOBAL ASAPIPRANT PERENNIAL ALLERGIC RHINITIS DRUG MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
4. GLOBAL APC-3000 PERENNIAL ALLERGIC RHINITIS DRUG MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
5. GLOBAL BILASTINE PERENNIAL ALLERGIC RHINITIS DRUG MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
6. GLOBAL OTHERS PERENNIAL ALLERGIC RHINITIS DRUG MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
7. GLOBAL PERENNIAL ALLERGIC RHINITIS DRUG MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
8. GLOBAL HOSPITALS PERENNIAL ALLERGIC RHINITIS DRUG MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
9. GLOBAL CLINICS PERENNIAL ALLERGIC RHINITIS DRUG MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
10. GLOBAL OTHERS PERENNIAL ALLERGIC RHINITIS DRUG MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
11. GLOBAL PERENNIAL ALLERGIC RHINITIS DRUG MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2021-2028 ($ MILLION)
12. NORTH AMERICAN PERENNIAL ALLERGIC RHINITIS DRUG MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
13. NORTH AMERICAN PERENNIAL ALLERGIC RHINITIS DRUG MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
14. NORTH AMERICAN PERENNIAL ALLERGIC RHINITIS DRUG MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
15. EUROPEAN PERENNIAL ALLERGIC RHINITIS DRUG MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
16. EUROPEAN PERENNIAL ALLERGIC RHINITIS DRUG MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
17. EUROPEAN PERENNIAL ALLERGIC RHINITIS DRUG MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
18. ASIA-PACIFIC PERENNIAL ALLERGIC RHINITIS DRUG MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
19. ASIA-PACIFIC PERENNIAL ALLERGIC RHINITIS DRUG MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
20. ASIA-PACIFIC PERENNIAL ALLERGIC RHINITIS DRUG MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
21. REST OF THE WORLD PERENNIAL ALLERGIC RHINITIS DRUG MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
22. REST OF THE WORLD PERENNIAL ALLERGIC RHINITIS DRUG MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
23. REST OF THE WORLD PERENNIAL ALLERGIC RHINITIS DRUG MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
1. IMPACT OF COVID-19 ON GLOBAL PERENNIAL ALLERGIC RHINITIS DRUG MARKET, 2021-2028 ($ MILLION)
2. IMPACT OF COVID-19 ON GLOBAL PERENNIAL ALLERGIC RHINITIS DRUG MARKET BY SEGMENT, 2021-2028 ($ MILLION)
3. RECOVERY OF GLOBAL PERENNIAL ALLERGIC RHINITIS DRUG MARKET, 2022-2028 (%)
4. GLOBAL PERENNIAL ALLERGIC RHINITIS DRUG MARKET SHARE BY DRUG TYPE, 2021 VS 2028 (%)
5. GLOBAL ANTIHISTAMINES PERENNIAL ALLERGIC RHINITIS DRUG MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
6. GLOBAL ASAPIPRANT PERENNIAL ALLERGIC RHINITIS DRUG MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
7. GLOBAL APC-3000 PERENNIAL ALLERGIC RHINITIS DRUG MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
8. GLOBAL BILASTINE PERENNIAL ALLERGIC RHINITIS DRUG MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
9. GLOBAL OTHERS PERENNIAL ALLERGIC RHINITIS DRUG MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
10. GLOBAL PERENNIAL ALLERGIC RHINITIS DRUG MARKET SHARE BY APPLICATION, 2021 VS 2028 (%)
11. GLOBAL HOSPITALS PERENNIAL ALLERGIC RHINITIS DRUG MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
12. GLOBAL CLINICS PERENNIAL ALLERGIC RHINITIS DRUG MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
13. GLOBAL OTHERS PERENNIAL ALLERGIC RHINITIS DRUG MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
14. GLOBAL PERENNIAL ALLERGIC RHINITIS DRUG MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
15. US PERENNIAL ALLERGIC RHINITIS DRUG MARKET SIZE, 2021-2028 ($ MILLION)
16. CANADA PERENNIAL ALLERGIC RHINITIS DRUG MARKET SIZE, 2021-2028 ($ MILLION)
17. UK PERENNIAL ALLERGIC RHINITIS DRUG MARKET SIZE, 2021-2028 ($ MILLION)
18. FRANCE PERENNIAL ALLERGIC RHINITIS DRUG MARKET SIZE, 2021-2028 ($ MILLION)
19. GERMANY PERENNIAL ALLERGIC RHINITIS DRUG MARKET SIZE, 2021-2028 ($ MILLION)
20. ITALY PERENNIAL ALLERGIC RHINITIS DRUG MARKET SIZE, 2021-2028 ($ MILLION)
21. SPAIN PERENNIAL ALLERGIC RHINITIS DRUG MARKET SIZE, 2021-2028 ($ MILLION)
22. REST OF EUROPE PERENNIAL ALLERGIC RHINITIS DRUG MARKET SIZE, 2021-2028 ($ MILLION)
23. INDIA PERENNIAL ALLERGIC RHINITIS DRUG MARKET SIZE, 2021-2028 ($ MILLION)
24. CHINA PERENNIAL ALLERGIC RHINITIS DRUG MARKET SIZE, 2021-2028 ($ MILLION)
25. JAPAN PERENNIAL ALLERGIC RHINITIS DRUG MARKET SIZE, 2021-2028 ($ MILLION)
26. REST OF THE ASIA-PACIFIC PERENNIAL ALLERGIC RHINITIS DRUG MARKET SIZE, 2021-2028 ($ MILLION)
27. REST OF THE WORLD PERENNIAL ALLERGIC RHINITIS DRUG MARKET SIZE, 2021-2028 ($ MILLION)
